Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX: PMTPMET Resources Inc.Materials

PMET Caesium Resource Rises to 110,600 t Contained Cs2O

PMET's updated Shaakichiuwaanaan resource lifts contained Cs2O to 110,600 t and contained LCE 5%, with an updated Feasibility Study expected before year end.

By Digifin Pty Ltd · About this coverage

Key Points

  • Caesium Zone Mineral Resource of 1,844,000 t at 4.40% Cs2O Indicated and 981,000 t at 3.00% Cs2O Inferred
  • Contained Cs2O rose from 71,000 t to 110,600 t, with maiden rubidium resource declared
  • Consolidated 113.9 Mt at 1.43% Li2O Indicated and 33.8 Mt at 1.24% Li2O Inferred; contained LCE up 5%
  • Updated Feasibility Study and Preliminary Economic Assessment expected before year end
  • Estimate does not materially change the current Mineral Reserve estimate, per PMET
PMET Resources Inc. (ASX:PMT)

About PMET Resources (ASX:PMT)

PMET Resources Inc. is a Montreal-headquartered critical minerals exploration and development company listed on the TSX, with its securities quoted on the ASX under the code PMT. It is developing the Shaakichiuwaanaan lithium project in the James Bay region of Quebec, Canada.

PMET released its fifth consolidated Mineral Resource Estimate for the Shaakichiuwaanaan Property in Quebec, which raises lithium, caesium and tantalum resources and is intended to underpin an updated Feasibility Study and a Preliminary Economic Assessment expected before year end.

The Caesium Zone MRE, within the CV13 Pegmatite, is 1,844,000 t at 4.40% Cs2O Indicated for 81,200 t of contained Cs2O and 981,000 t at 3.00% Cs2O Inferred for 29,400 t. PMET says contained Cs2O rose from 71,000 t to 110,600 t, and a maiden rubidium resource is declared at 0.46% Rb2O Indicated and 0.37% Rb2O Inferred. The consolidated estimate for CV5, CV13 and CV4 is 113.9 Mt at 1.43% Li2O and 164 ppm Ta2O5 Indicated for 4.03 Mt LCE, and 33.8 Mt at 1.24% Li2O and 150 ppm Ta2O5 Inferred for 1.03 Mt LCE. Contained LCE is up 5%, and CV4 adds a maiden Inferred resource of 1.75 Mt at 1.24% Li2O. The effective date is July 10, 2026, and the independent Competent Person and Qualified Person is Todd McCracken of BBA Consultants. PMET says the estimate does not materially change the current Mineral Reserve estimate or the economic conclusions of the CV5 Lithium-Only Feasibility Study announced October 20, 2025.

Mineral Resources are not Mineral Reserves and do not have demonstrated economic viability. The Preliminary Economic Assessment is to provide the first preliminary economic evaluation of caesium for the Project. Drilling completed in 2026 is excluded and is anticipated to feed a 2027 update.

Back to all ASX Company News

Source: PMET Resources Inc. (ASX:PMT), 4 November 2026. Summary content supplied by Digifin Pty Ltd.

News summary only, not financial advice. It does not consider your objectives, financial situation or needs.

Wednesday, 4 November 2026

Also summarised today

All ASX Company News
ASX: BGDMaterials

Barton Gold Starts Challenger Underground Scoping Study

Barton Gold has started a Scoping Study on Challenger underground feed for the Central Gawler Mill, after underground Resources more than doubled to 230koz.

4 Nov, 9:06 am AEDT
ASX: BTRMaterials

Brightstar Identifies 11 Sandstone Intrusive Targets

Brightstar has identified 11 felsic intrusive targets at Sandstone analogous to Two Mile Hill and Bull Oak, with RC drilling scheduled to start in November.

4 Nov, 9:40 am AEDT
ASX: DTRMaterials

Dateline and US Government Seek Ninth Circuit Stay

Dateline and the US Government each filed Ninth Circuit motions to stay a preliminary injunction pending appeal, aiming to let work at Colosseum resume.

4 Nov, 8:56 am AEDT
ASX: GMGReal Estate

Goodman Q1 FY27 A$90.0bn Portfolio; 9% Operating EPS Target

Goodman's Q1 FY27 update reports an A$90.0 billion portfolio and A$19.7 billion of work in progress, with a stated FY27 target of 9% operating EPS growth.

4 Nov, 8:23 am AEDT
ASX: ILAHealth Care

Island Pharma Starts Primate Surgeries for Marburg Study

Island Pharma has begun surgeries on 22 non-human primates at USAMRIID ahead of its Galidesivir Marburg dose study, with dosing expected in early December.

4 Nov, 9:30 am AEDT
ASX: INAReal Estate

Ingenia Says It Did Not Brief Media on Proposals

Ingenia told ASX neither it nor anyone representing it briefed media on the AVID and Warburg Pincus proposals, and it is unaware how it was published.

4 Nov, 9:06 am AEDT
ASX: POLMaterials

Polymetals October Ore Processed 40,790 t, Guidance Held

Polymetals processed 40,790 tonnes at Endeavor in October, 79.1% above the September Quarter monthly average, at lower silver grade, with guidance unchanged.

4 Nov, 8:23 am AEDT
ASX: VALMaterials

Valiant Gold Commissions Comet 6.1 MW Power Station

Valiant Gold has commissioned the 6.1 MW Comet power station, with ventilation running and dewatering progressing, and targets first production in H2 FY27.

4 Nov, 8:45 am AEDT
ASX: WTMMaterials

Waratah Declares Maiden 3.1 Moz Au Resource at Spur

Waratah has declared a maiden Spur Mineral Resource of 3.1 Moz Au at 1.2 g/t and a conceptual Exploration Target of 5.1 to 10.4 Moz Au, with drilling planned.

4 Nov, 9:29 am AEDT

Announcement summaries are published each trading day. General advice only.

Copyright © 2026 SureStone Capital